Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(irinotecan). Showing records 1 – 30 of 66 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters

1. Vamvakas, Lampros. Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου.

Degree: 2014, University of Crete (UOC); Πανεπιστήμιο Κρήτης

 Colorectal cancer (CRC) represents 10% of all new cancer cases and is the third most common neoplasm in men and the second in women. The… (more)

Subjects/Keywords: Ιρινοτεκάνη; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vamvakas, L. (2014). Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου. (Thesis). University of Crete (UOC); Πανεπιστήμιο Κρήτης. Retrieved from http://hdl.handle.net/10442/hedi/34895

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vamvakas, Lampros. “Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου.” 2014. Thesis, University of Crete (UOC); Πανεπιστήμιο Κρήτης. Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/34895.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vamvakas, Lampros. “Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου.” 2014. Web. 14 Apr 2021.

Vancouver:

Vamvakas L. Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου. [Internet] [Thesis]. University of Crete (UOC); Πανεπιστήμιο Κρήτης; 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/34895.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vamvakas L. Ο ρόλος της Ιρινοτεκάνης (CPT-11) στη θεραπευτική αντιμετώπιση του μεταστατικού καρκίνου του παχέος εντέρου. [Thesis]. University of Crete (UOC); Πανεπιστήμιο Κρήτης; 2014. Available from: http://hdl.handle.net/10442/hedi/34895

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Adelaide

2. Fakiha, Khloud G. A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis.

Degree: 2015, University of Adelaide

 Gastrointestinal mucositis (GIM) has become increasingly recognised as a major toxicity of cancer treatment. The efficacy and safe use of irinotecan (a topoisomerase I inhibitor… (more)

Subjects/Keywords: gastrointestinal; mucositis; toll-like receptors; irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fakiha, K. G. (2015). A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/92339

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fakiha, Khloud G. “A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis.” 2015. Thesis, University of Adelaide. Accessed April 14, 2021. http://hdl.handle.net/2440/92339.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fakiha, Khloud G. “A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis.” 2015. Web. 14 Apr 2021.

Vancouver:

Fakiha KG. A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis. [Internet] [Thesis]. University of Adelaide; 2015. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2440/92339.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fakiha KG. A study linking toll-like receptors and irinotecan-induced gastrointestinal mucositis. [Thesis]. University of Adelaide; 2015. Available from: http://hdl.handle.net/2440/92339

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

3. Tandia, Mahamadou. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.

Degree: Docteur es, Sciences pharmacologiques, 2017, Université Paris-Saclay (ComUE)

Le traitement des cancers constitue un problème de santé publique et repose entre autres sur la chirurgie, la radiothérapie, la chimiothérapie, l’hormonothérapie et les thérapies… (more)

Subjects/Keywords: Abcb1; Pharmacocinetique; Pharmacogenetique; Bevacizumab; Sorafenib; Irinotecan; Abcb1; Pharmakinetics; Pharmacogentics; Bevacizumab; Sorafenib; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tandia, M. (2017). INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2017SACLS424

Chicago Manual of Style (16th Edition):

Tandia, Mahamadou. “INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.” 2017. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed April 14, 2021. http://www.theses.fr/2017SACLS424.

MLA Handbook (7th Edition):

Tandia, Mahamadou. “INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.” 2017. Web. 14 Apr 2021.

Vancouver:

Tandia M. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2017. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2017SACLS424.

Council of Science Editors:

Tandia M. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2017. Available from: http://www.theses.fr/2017SACLS424

4. Mazard, Thibault. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.

Degree: Docteur es, Cancérologie-Radiothérapie, 2013, Université Montpellier I

Le traitement médical du cancer colorectal a connu ces dernières années d'importantes avancées avec l'arrivée notamment des thérapies ciblées anti-angiogéniques et anti-EGFR. Néanmoins ces molécules… (more)

Subjects/Keywords: Cancer colorectal métastatique; Irinotecan; Bevacizumab; Sorafenib; Abcg2; Densité tumorale; Metastatic colorectal cancer; Irinotecan; Bevacizumab; Sorafenib; Abcg2; Tumoral density

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mazard, T. (2013). Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2013MON1T017

Chicago Manual of Style (16th Edition):

Mazard, Thibault. “Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.” 2013. Doctoral Dissertation, Université Montpellier I. Accessed April 14, 2021. http://www.theses.fr/2013MON1T017.

MLA Handbook (7th Edition):

Mazard, Thibault. “Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.” 2013. Web. 14 Apr 2021.

Vancouver:

Mazard T. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. [Internet] [Doctoral dissertation]. Université Montpellier I; 2013. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2013MON1T017.

Council of Science Editors:

Mazard T. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. [Doctoral Dissertation]. Université Montpellier I; 2013. Available from: http://www.theses.fr/2013MON1T017


Université Paris-Sud – Paris XI

5. Ballesta, Annabelle. Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies.

Degree: Docteur es, Pharmacologie et modélisation mathématique, 2011, Université Paris-Sud – Paris XI

 Personnaliser les traitements anticancéreux sur base moléculaire consiste à optimiser la thérapie en fonction des profils d'expression de gènes des cellules saines et tumorales du… (more)

Subjects/Keywords: Optimisation thérapeutique; Pharmacocinétique-pharmacodynamie moléculaire; Irinotecan; SRC; Therapeutics optimization; Cancer; Mathematical modeling; Systems biology; Molecular pharmacokinetics-pharmacodynamics; Circadian rhythm; Irinotecan; SRC

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ballesta, A. (2011). Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2011PA114810

Chicago Manual of Style (16th Edition):

Ballesta, Annabelle. “Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies.” 2011. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed April 14, 2021. http://www.theses.fr/2011PA114810.

MLA Handbook (7th Edition):

Ballesta, Annabelle. “Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies.” 2011. Web. 14 Apr 2021.

Vancouver:

Ballesta A. Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2011. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2011PA114810.

Council of Science Editors:

Ballesta A. Approche combinée expérimentale et mathématique pour la personnalisation sur base moléculaire des thérapies anticancéreuses standards et chronomodulées : A combined experimental and mathematical approach for molecular-based personalization of chronomodulated and standard anticancer therapies. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2011. Available from: http://www.theses.fr/2011PA114810

6. Tziotou, Marianna. Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους.

Degree: 2014, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Uridine Glucuronosyltransferase (UGT) gene polymorphisms have been linked to irinotecan toxicity.UGT1A1 is the responsible enzyme for the detoxification of the active metabolite of the drug… (more)

Subjects/Keywords: Γλυκουρονοσυλτρανσφεράση; Ιρινοτεκάνη; Δόση; Τοξικότητα; Uridine glucuronosyltransferase; Irinotecan; Dose; Toxicity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tziotou, M. (2014). Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/41788

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tziotou, Marianna. “Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους.” 2014. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/41788.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tziotou, Marianna. “Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους.” 2014. Web. 14 Apr 2021.

Vancouver:

Tziotou M. Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2014. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/41788.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tziotou M. Σχέση των πολυμορφισμών του γονιδίου UGT1A με την τοξικότητα της ιρινοτεκάνης (CPT-11) σε Έλληνες ασθενείς σε συμπαγείς όγκους. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2014. Available from: http://hdl.handle.net/10442/hedi/41788

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

7. Isaakidou, Athina. Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη.

Degree: 2016, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

The aim of our study was to analyze the possible relationships between treatment efficacy, and germinal gene polymorphisms linked to the irinotecan in combination with… (more)

Subjects/Keywords: Μεταστατικός καρκίνος παχέος εντέρου; Ιρινοτεκάνη; Metastatic colorectal cancer; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Isaakidou, A. (2016). Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/38016

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Isaakidou, Athina. “Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη.” 2016. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/38016.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Isaakidou, Athina. “Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη.” 2016. Web. 14 Apr 2021.

Vancouver:

Isaakidou A. Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/38016.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Isaakidou A. Φαρμακογενετική ανάλυση ασθενών με ορθοκολικό καρκίνο και συσχέτιση με ανταπόκριση στους χημειοθεραπευτικούς συνδυασμούς με ιρινοτεκάνη. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2016. Available from: http://hdl.handle.net/10442/hedi/38016

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


North Carolina State University

8. Nolan, Jason Michael. The Synthesis of (S)-Camptothecin and Clinically Useful Analogs.

Degree: PhD, Chemistry, 2003, North Carolina State University

 A six-step synthesis of (S)-camptothecin (CPT) was completed relinquishing a fast, efficient route to this natural product. The key steps included the formation of the… (more)

Subjects/Keywords: irinotecan; camptothecin; haloquinolines; karenitecin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nolan, J. M. (2003). The Synthesis of (S)-Camptothecin and Clinically Useful Analogs. (Doctoral Dissertation). North Carolina State University. Retrieved from http://www.lib.ncsu.edu/resolver/1840.16/3716

Chicago Manual of Style (16th Edition):

Nolan, Jason Michael. “The Synthesis of (S)-Camptothecin and Clinically Useful Analogs.” 2003. Doctoral Dissertation, North Carolina State University. Accessed April 14, 2021. http://www.lib.ncsu.edu/resolver/1840.16/3716.

MLA Handbook (7th Edition):

Nolan, Jason Michael. “The Synthesis of (S)-Camptothecin and Clinically Useful Analogs.” 2003. Web. 14 Apr 2021.

Vancouver:

Nolan JM. The Synthesis of (S)-Camptothecin and Clinically Useful Analogs. [Internet] [Doctoral dissertation]. North Carolina State University; 2003. [cited 2021 Apr 14]. Available from: http://www.lib.ncsu.edu/resolver/1840.16/3716.

Council of Science Editors:

Nolan JM. The Synthesis of (S)-Camptothecin and Clinically Useful Analogs. [Doctoral Dissertation]. North Carolina State University; 2003. Available from: http://www.lib.ncsu.edu/resolver/1840.16/3716


University of Adelaide

9. Al-Azri, Abdul Rahman. The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model.

Degree: 2013, University of Adelaide

 Background: Chemotherapy-induced oral mucositis is defined as damage of oral mucosa caused by unwanted detrimental effects of the cytotoxic chemotherapy. Oral mucositis presents as widespread… (more)

Subjects/Keywords: oral mucositis; matrix metalloproteinases; MMPs; tissuee inhibitors of metalloproteinase; TIMPs; irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Al-Azri, A. R. (2013). The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/81399

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Al-Azri, Abdul Rahman. “The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model.” 2013. Thesis, University of Adelaide. Accessed April 14, 2021. http://hdl.handle.net/2440/81399.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Al-Azri, Abdul Rahman. “The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model.” 2013. Web. 14 Apr 2021.

Vancouver:

Al-Azri AR. The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model. [Internet] [Thesis]. University of Adelaide; 2013. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/2440/81399.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Al-Azri AR. The role of matrix metalloproteinases and their inhibitors in irinotecan-induced oral mucositis: an animal model. [Thesis]. University of Adelaide; 2013. Available from: http://hdl.handle.net/2440/81399

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Bol, Jessica. Personalized Irinotecan Treatment: the patient matters.

Degree: 2011, Erasmus University Medical Center

 textabstractIn the early sixties of the last century, camptothecin (CPT) was isolated from the Chinese plant Camptotheca acuminata (Nyssaceae family), and was found to be… (more)

Subjects/Keywords: irinotecan treatment; pharmacology

…CONTENTS Chapter 1 Introduction Chapter 2 Cigarette smoking and irinotecan treatment… …x29;: 2719-26. 20 Chapter 3 Effects of mannose-binding lectin polymorphisms on irinotecan… …Renal function as a predictor of irinotecan-induced neutropenia. Clinical Pharmacology… …pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug-drug… …of methimazole on the elimination of irinotecan. Cancer Chemotherapy and Pharmacology 2011… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bol, J. (2011). Personalized Irinotecan Treatment: the patient matters. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/23661

Chicago Manual of Style (16th Edition):

Bol, Jessica. “Personalized Irinotecan Treatment: the patient matters.” 2011. Doctoral Dissertation, Erasmus University Medical Center. Accessed April 14, 2021. http://hdl.handle.net/1765/23661.

MLA Handbook (7th Edition):

Bol, Jessica. “Personalized Irinotecan Treatment: the patient matters.” 2011. Web. 14 Apr 2021.

Vancouver:

Bol J. Personalized Irinotecan Treatment: the patient matters. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 2011. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1765/23661.

Council of Science Editors:

Bol J. Personalized Irinotecan Treatment: the patient matters. [Doctoral Dissertation]. Erasmus University Medical Center; 2011. Available from: http://hdl.handle.net/1765/23661

11. Vergadis, Chrysovalantis. Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά.

Degree: 2018, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Background: Transarterial chemoembolization (TACE) has been investigated in patients with colorectal cancer liver metastases (CCLM). Limited experience and available data suggest that TACE can achieve… (more)

Subjects/Keywords: Χημειοεμβολισμός; Ηπατικές μεταστάσεις; Ορθοκολικός καρκίνος; Ιρινοτεκάνη; Chemoembolization; colorectal liver metastases; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vergadis, C. (2018). Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/43885

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vergadis, Chrysovalantis. “Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά.” 2018. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/43885.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vergadis, Chrysovalantis. “Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά.” 2018. Web. 14 Apr 2021.

Vancouver:

Vergadis C. Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/43885.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vergadis C. Διακαθετηριακή θεραπεία μεταστατικού καρκίνου του ήπατος με σφαιρίδια που απελευθερώνουν χημειοθεραπευτικά. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2018. Available from: http://hdl.handle.net/10442/hedi/43885

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Marcelo Leite Vieira Costa. Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano.

Degree: 2012, Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Farmacologia; UFC; BR

nÃo hÃ

IntroduÃÃo: A esteatohepatite nÃo alcoÃlica (NASH) Ã um evento adverso do quimioterÃpico irinotecano extremamente relevante, pois associa-se a uma maior mortalidade apÃs ressecÃÃes… (more)

Subjects/Keywords: Irinotecano; Irinotecan; steatohepatitis; bacterial translocation; cytokines; nitric oxide; FARMACOLOGIA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Costa, M. L. V. (2012). Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano. (Doctoral Dissertation). Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Farmacologia; UFC; BR. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=10193

Chicago Manual of Style (16th Edition):

Costa, Marcelo Leite Vieira. “Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano.” 2012. Doctoral Dissertation, Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Farmacologia; UFC; BR. Accessed April 14, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=10193.

MLA Handbook (7th Edition):

Costa, Marcelo Leite Vieira. “Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano.” 2012. Web. 14 Apr 2021.

Vancouver:

Costa MLV. Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano. [Internet] [Doctoral dissertation]. Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Farmacologia; UFC; BR; 2012. [cited 2021 Apr 14]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=10193.

Council of Science Editors:

Costa MLV. Desenvolvimento de um modelo experimental de esteatohepatite induzida pelo antineoplÃsico irinotecano. [Doctoral Dissertation]. Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Farmacologia; UFC; BR; 2012. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=10193

13. Aline Almeida Figueiredo. Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano.

Degree: 2012, Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Cirurgia; UFC; BR

Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico

IntroduÃÃo: A mucosite intestinal (MI) Ã um efeito colateral comum e limitante da quimioterapia com irinotecano. Estudos sugerem… (more)

Subjects/Keywords: Irinotecan, mucositis, TNF-α;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Figueiredo, A. A. (2012). Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano. (Masters Thesis). Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Cirurgia; UFC; BR. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11524

Chicago Manual of Style (16th Edition):

Figueiredo, Aline Almeida. “Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano.” 2012. Masters Thesis, Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Cirurgia; UFC; BR. Accessed April 14, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11524.

MLA Handbook (7th Edition):

Figueiredo, Aline Almeida. “Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano.” 2012. Web. 14 Apr 2021.

Vancouver:

Figueiredo AA. Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano. [Internet] [Masters thesis]. Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Cirurgia; UFC; BR; 2012. [cited 2021 Apr 14]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11524.

Council of Science Editors:

Figueiredo AA. Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano. [Masters Thesis]. Universidade Federal do CearÃ; Programa de PÃs-GraduaÃÃo em Cirurgia; UFC; BR; 2012. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=11524

14. Nguyen, Aurélia. Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2014, Université de Strasbourg

Les gliomes malins de l’enfant (GME), de pronostic sombre, se distinguent des gliomes malins de l’adulte (GMA) sur le plan biologique mais aussi clinique, avec… (more)

Subjects/Keywords: Gliomes malins pédiatriques; Temozolomide; MGMT; Hypoxie intra-tumorale; HIF; Métabolomique; Rapamycine; Irinotecan; Pediatric malignant glioma; Temozolomide; MGMT; Intra-tumor hypoxia; HIF; Metabolomics; Rapamycin; Irinotecan; 572.8; 616.99

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nguyen, A. (2014). Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia. (Doctoral Dissertation). Université de Strasbourg. Retrieved from http://www.theses.fr/2014STRAJ086

Chicago Manual of Style (16th Edition):

Nguyen, Aurélia. “Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia.” 2014. Doctoral Dissertation, Université de Strasbourg. Accessed April 14, 2021. http://www.theses.fr/2014STRAJ086.

MLA Handbook (7th Edition):

Nguyen, Aurélia. “Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia.” 2014. Web. 14 Apr 2021.

Vancouver:

Nguyen A. Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia. [Internet] [Doctoral dissertation]. Université de Strasbourg; 2014. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2014STRAJ086.

Council of Science Editors:

Nguyen A. Mécanismes de résistance à la chimiothérapie dans les gliomes de haut grade de l’enfant : implications des systèmes de réparation de l’ADN et de l’hypoxie intra-tumorale : Mechanisms of chemo-resistance in pediatric malignant gliomas : involvement of DNA repair system and intra-tumor hypoxia. [Doctoral Dissertation]. Université de Strasbourg; 2014. Available from: http://www.theses.fr/2014STRAJ086


University of Vienna

15. Wimmer, Lisa. Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell.

Degree: 2017, University of Vienna

Zur Beurteilung der Verteilung und der Transferrate in das Tumorgewebe von Irinotecan nach unterschiedlichen Arten der Verabreichung wurden Plasma-, Leber- und Tumorproben von Ratten analysiert.… (more)

Subjects/Keywords: 44.40 Pharmazie, Pharmazeutika; 44.81 Onkologie; 44.42 Pharmazeutische Chemie; Chemoembolisation / Irinotecan / CPT-11 / SN-38 / hepatozelluläres Karzinom / Rattenmodell; chemoembolization / irinotecan / CPT-11 / SN-38 / hepatocellular carcinoma / rat model

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wimmer, L. (2017). Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/50427/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wimmer, Lisa. “Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell.” 2017. Thesis, University of Vienna. Accessed April 14, 2021. http://othes.univie.ac.at/50427/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wimmer, Lisa. “Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell.” 2017. Web. 14 Apr 2021.

Vancouver:

Wimmer L. Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell. [Internet] [Thesis]. University of Vienna; 2017. [cited 2021 Apr 14]. Available from: http://othes.univie.ac.at/50427/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wimmer L. Chemoembolisation mit Irinotecan in der Therapie des hepatozellulären Karzinoms im Rattenmodell. [Thesis]. University of Vienna; 2017. Available from: http://othes.univie.ac.at/50427/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

16. Sawano, Takeyuki. Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン.

Degree: 博士(医学), 2018, Hirosaki University / 弘前大学

Using a rat model, I investigated factors contributing to the pathogenesis of irinotecan-associated fatty liver disease. Male Sprague-Dawley rats were administered 200 mg/kg irinotecan by… (more)

Subjects/Keywords: fatty acid synthase; liver progenitor cell; Kupffer cell; chemotherapy-associated steatohepatitis; irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sawano, T. (2018). Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン. (Thesis). Hirosaki University / 弘前大学. Retrieved from http://hdl.handle.net/10129/5663

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sawano, Takeyuki. “Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン.” 2018. Thesis, Hirosaki University / 弘前大学. Accessed April 14, 2021. http://hdl.handle.net/10129/5663.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sawano, Takeyuki. “Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン.” 2018. Web. 14 Apr 2021.

Vancouver:

Sawano T. Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン. [Internet] [Thesis]. Hirosaki University / 弘前大学; 2018. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10129/5663.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sawano T. Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan : Irinotecan投与によるラット肝の脂肪化誘発とそれに先行する脂肪酸合成酵素陽性細胞の出現; Irinotecan トウヨ ニヨル ラットカン ノ シボウカ ユウハツ ト ソレニ センコウ スル シボウサン ゴウセイ コウソ ヨウセイ サイボウ ノ シュツゲン. [Thesis]. Hirosaki University / 弘前大学; 2018. Available from: http://hdl.handle.net/10129/5663

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Alberta

17. Farhangfar, Arazm. Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen.

Degree: MS, Department of Agricultural, Food, and Nutritional Science, 2012, University of Alberta

 Aim of this study was to assess effects of non-digestible carbohydrates on the pathobiology of mucosal injury after chemotherapy. Rats bearing colon tumor (n=6/diet) were… (more)

Subjects/Keywords: Side effect; Toxicity; Adverse effect; Dietary fiber; Irinotecan; CPT-11; Non-digestible carbohydrate; NDCHO; Chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Farhangfar, A. (2012). Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/mw22v651x

Chicago Manual of Style (16th Edition):

Farhangfar, Arazm. “Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen.” 2012. Masters Thesis, University of Alberta. Accessed April 14, 2021. https://era.library.ualberta.ca/files/mw22v651x.

MLA Handbook (7th Edition):

Farhangfar, Arazm. “Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen.” 2012. Web. 14 Apr 2021.

Vancouver:

Farhangfar A. Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen. [Internet] [Masters thesis]. University of Alberta; 2012. [cited 2021 Apr 14]. Available from: https://era.library.ualberta.ca/files/mw22v651x.

Council of Science Editors:

Farhangfar A. Non digestible carbohydrates in the diet determine toxicity of irinotecan (CPT-11)/5-fluorouracil in rats independently of β-glucuronidase activity in intestinal lumen. [Masters Thesis]. University of Alberta; 2012. Available from: https://era.library.ualberta.ca/files/mw22v651x


University of Alberta

18. Almasud, Alaa A. Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU.

Degree: MS, Department of Agricultural, Food, and Nutritional Science, 2012, University of Alberta

 This study aimed to assess the effect of irinotecan / 5-fluorouracil treatment on amount and types of fatty acids in skeletal muscles of tumor-bearing rats… (more)

Subjects/Keywords: Colorectal Cancer; Sarcopenia; Essential Fatty Acids; Skeletal Muscle; EPA and DHA; Cachexia; irinotecan / 5-fluorouracil

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almasud, A. A. (2012). Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/08612p101

Chicago Manual of Style (16th Edition):

Almasud, Alaa A. “Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU.” 2012. Masters Thesis, University of Alberta. Accessed April 14, 2021. https://era.library.ualberta.ca/files/08612p101.

MLA Handbook (7th Edition):

Almasud, Alaa A. “Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU.” 2012. Web. 14 Apr 2021.

Vancouver:

Almasud AA. Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU. [Internet] [Masters thesis]. University of Alberta; 2012. [cited 2021 Apr 14]. Available from: https://era.library.ualberta.ca/files/08612p101.

Council of Science Editors:

Almasud AA. Elevated Fatty Acid Content in Muscle is Prevented by EPA and DHA in an Animal Model of Colorectal Cancer Receiving CPT-11 / 5-FU. [Masters Thesis]. University of Alberta; 2012. Available from: https://era.library.ualberta.ca/files/08612p101

19. Tuy, Hoang Dinh. ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.

Degree: 博士(医学), 2017, Shiga University of Medical Science / 滋賀医科大学

Subjects/Keywords: colorectal adenocarcinoma; ABCG2; irinotecan; drug resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tuy, H. D. (2017). ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. (Thesis). Shiga University of Medical Science / 滋賀医科大学. Retrieved from http://hdl.handle.net/10422/00012255

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tuy, Hoang Dinh. “ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.” 2017. Thesis, Shiga University of Medical Science / 滋賀医科大学. Accessed April 14, 2021. http://hdl.handle.net/10422/00012255.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tuy, Hoang Dinh. “ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.” 2017. Web. 14 Apr 2021.

Vancouver:

Tuy HD. ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. [Internet] [Thesis]. Shiga University of Medical Science / 滋賀医科大学; 2017. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10422/00012255.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tuy HD. ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan. [Thesis]. Shiga University of Medical Science / 滋賀医科大学; 2017. Available from: http://hdl.handle.net/10422/00012255

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Paris-Sud – Paris XI

20. Baylatry, Minh-Tâm. Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release.

Degree: Docteur es, Pharmacologie expérimentale et clinique, 2011, Université Paris-Sud – Paris XI

La chimioembolisation est une thérapie loco-régionale qui consiste à injecter, au moyend’un microcathéter, un principe actif et un agent d’occlusion vasculaire de manière la plussélective… (more)

Subjects/Keywords: Chimioembolisation du Poumon; Microsphère; Chemoembolization; Drug-eluting-beads; Irinotecan; Sirolimus; Pharmacokinetics; Lung

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baylatry, M. (2011). Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2011PA114819

Chicago Manual of Style (16th Edition):

Baylatry, Minh-Tâm. “Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release.” 2011. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed April 14, 2021. http://www.theses.fr/2011PA114819.

MLA Handbook (7th Edition):

Baylatry, Minh-Tâm. “Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release.” 2011. Web. 14 Apr 2021.

Vancouver:

Baylatry M. Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2011. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2011PA114819.

Council of Science Editors:

Baylatry M. Microsphères de chimioembolisation appliquées au poumon : étude de la libération in vivo d'anticancéreux : Lung chemoembolization with drug eluting beads : in vivo evaluation of anticancer drug release. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2011. Available from: http://www.theses.fr/2011PA114819

21. Jonchère, Barbara. Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2014, Angers

Les dommages de l’ADN, induits par les traitements de chimiothérapie, sont responsables de l’induction de la sénescence, un arrêt définitif du cycle cellulaire dépendant des… (more)

Subjects/Keywords: Chimiothérapie; Sénescence; Irinotécan; Chimiorésistance; Cancer colorectal; Chemotherapy; Senescence; Irinotecan; Chemoresistance; Colorectal cancer; 616

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jonchère, B. (2014). Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity. (Doctoral Dissertation). Angers. Retrieved from http://www.theses.fr/2014ANGE0008

Chicago Manual of Style (16th Edition):

Jonchère, Barbara. “Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity.” 2014. Doctoral Dissertation, Angers. Accessed April 14, 2021. http://www.theses.fr/2014ANGE0008.

MLA Handbook (7th Edition):

Jonchère, Barbara. “Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity.” 2014. Web. 14 Apr 2021.

Vancouver:

Jonchère B. Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity. [Internet] [Doctoral dissertation]. Angers; 2014. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2014ANGE0008.

Council of Science Editors:

Jonchère B. Echappement à la chimiothérapie et émergence de cellules plus agressives : Importance de l’hétérogénéité tumorale : Chemotherapy escape and emergence of more aggressive cells : A critical role for tumoral heterogeneity. [Doctoral Dissertation]. Angers; 2014. Available from: http://www.theses.fr/2014ANGE0008


Université Montpellier II

22. Paillas, Salomé. Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement.

Degree: Docteur es, Biologie Santé, 2011, Université Montpellier II

Malgré les récentes avancées réalisées dans le traitement du cancer du côlon, la résistance des tumeurs est une cause fréquente de l'échec des chimiothérapies. Cette… (more)

Subjects/Keywords: MAPK p38; Résistance; Autophagie; Cancer; Irinotécan; P38 MAPK; Resistance; Autophagy; Cancer; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Paillas, S. (2011). Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement. (Doctoral Dissertation). Université Montpellier II. Retrieved from http://www.theses.fr/2011MON20058

Chicago Manual of Style (16th Edition):

Paillas, Salomé. “Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement.” 2011. Doctoral Dissertation, Université Montpellier II. Accessed April 14, 2021. http://www.theses.fr/2011MON20058.

MLA Handbook (7th Edition):

Paillas, Salomé. “Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement.” 2011. Web. 14 Apr 2021.

Vancouver:

Paillas S. Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement. [Internet] [Doctoral dissertation]. Université Montpellier II; 2011. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2011MON20058.

Council of Science Editors:

Paillas S. Étude des mécanismes de résistance à l’Irinotécan dans le cancer colorectal : implication de la MAPK p38 : Study of the resistance's mechanisms to Irinotecan in colorectal cancer : p38 MAPK's involvement. [Doctoral Dissertation]. Université Montpellier II; 2011. Available from: http://www.theses.fr/2011MON20058

23. 백, 옥주. Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients.

Degree: 2011, Ajou University

배경: 옥살리플라틴과 이리노테칸은 전이성 대장암 환자에서 5-FU와 함께 투여하여 FOLFOX 또는 FOLFIRI용법으로 일차치료로서 가장 많이 사용되는 항암제이다. 본 연구의 목적은 전이성 대장암 환자에서 전향적 연구로서… (more)

Subjects/Keywords: 대장암; 유전자 다형성; 맞춤화학치료; Oxaliplatin; Irinotecan; Tailored Chemotherapy; Colorectal Cancer; Genomic Polymorphism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

백, . (2011). Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/4407 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000011847

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

백, 옥주. “Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients.” 2011. Thesis, Ajou University. Accessed April 14, 2021. http://repository.ajou.ac.kr/handle/201003/4407 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000011847.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

백, 옥주. “Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients.” 2011. Web. 14 Apr 2021.

Vancouver:

백 . Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients. [Internet] [Thesis]. Ajou University; 2011. [cited 2021 Apr 14]. Available from: http://repository.ajou.ac.kr/handle/201003/4407 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000011847.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

백 . Tailored chemotherapy based on genomic polymorphisms for metastatic colorectal cancer treated with 5-fluorouracil plus oxaliplatin or irinotecan in Korean patients. [Thesis]. Ajou University; 2011. Available from: http://repository.ajou.ac.kr/handle/201003/4407 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000011847

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

24. Thuß, Peter. Optimizing chemotherapy for gastric cancer.

Degree: 2014, Freie Universität Berlin

 Gastric cancer has a poor prognosis. Therefore there is a great need for improvements of systemic therapy in terms of optimizing tolerability and improving efficacy.… (more)

Subjects/Keywords: gastric cancer; chemotherapy; Irinotecan; Docetaxel; Capecitabin; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thuß, P. (2014). Optimizing chemotherapy for gastric cancer. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-14351

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Thuß, Peter. “Optimizing chemotherapy for gastric cancer.” 2014. Thesis, Freie Universität Berlin. Accessed April 14, 2021. http://dx.doi.org/10.17169/refubium-14351.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Thuß, Peter. “Optimizing chemotherapy for gastric cancer.” 2014. Web. 14 Apr 2021.

Vancouver:

Thuß P. Optimizing chemotherapy for gastric cancer. [Internet] [Thesis]. Freie Universität Berlin; 2014. [cited 2021 Apr 14]. Available from: http://dx.doi.org/10.17169/refubium-14351.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Thuß P. Optimizing chemotherapy for gastric cancer. [Thesis]. Freie Universität Berlin; 2014. Available from: http://dx.doi.org/10.17169/refubium-14351

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

25. Mathijssen, Ron. Irinotecan: from clinical pharmacokinetics to pharmacogenetics.

Degree: 2002, Erasmus University Medical Center

 textabstractFour decades ago, a plant alkaloid was isolated from the Chinese tree Camptotheca acuminata (Nyssaceae family), which showed promising antitumor activity in vitro (1 ).… (more)

Subjects/Keywords: GPT-11; SN-38; irinotecan; pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mathijssen, R. (2002). Irinotecan: from clinical pharmacokinetics to pharmacogenetics. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/31545

Chicago Manual of Style (16th Edition):

Mathijssen, Ron. “Irinotecan: from clinical pharmacokinetics to pharmacogenetics.” 2002. Doctoral Dissertation, Erasmus University Medical Center. Accessed April 14, 2021. http://hdl.handle.net/1765/31545.

MLA Handbook (7th Edition):

Mathijssen, Ron. “Irinotecan: from clinical pharmacokinetics to pharmacogenetics.” 2002. Web. 14 Apr 2021.

Vancouver:

Mathijssen R. Irinotecan: from clinical pharmacokinetics to pharmacogenetics. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 2002. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/1765/31545.

Council of Science Editors:

Mathijssen R. Irinotecan: from clinical pharmacokinetics to pharmacogenetics. [Doctoral Dissertation]. Erasmus University Medical Center; 2002. Available from: http://hdl.handle.net/1765/31545

26. SHAIKH MOHAMMED ISHAQUE. DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER.

Degree: 2011, National University of Singapore

Subjects/Keywords: Ovarian cancer; doxorubicin; irinotecan; synergism; liposome

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

ISHAQUE, S. M. (2011). DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/29984

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

ISHAQUE, SHAIKH MOHAMMED. “DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER.” 2011. Thesis, National University of Singapore. Accessed April 14, 2021. http://scholarbank.nus.edu.sg/handle/10635/29984.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

ISHAQUE, SHAIKH MOHAMMED. “DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER.” 2011. Web. 14 Apr 2021.

Vancouver:

ISHAQUE SM. DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER. [Internet] [Thesis]. National University of Singapore; 2011. [cited 2021 Apr 14]. Available from: http://scholarbank.nus.edu.sg/handle/10635/29984.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

ISHAQUE SM. DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER. [Thesis]. National University of Singapore; 2011. Available from: http://scholarbank.nus.edu.sg/handle/10635/29984

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

27. Chatzimpaloglou, Anthoula. Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας.

Degree: 2020, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

The first aim of the present thesis was the study of the photolytic and photocatalytic degradation of three anticancer compounds (etoposide, irinotecan, methotrexate) using UV… (more)

Subjects/Keywords: Αντικαρκινικά φάρμακα; Φωτοκατάλυση; Διοξείδιο του τιτανίου TiO2; Προϊόντα μετασχηματισμού; Etoposide; Irinotecan; Methotrexate; Photocatalysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chatzimpaloglou, A. (2020). Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/47341

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chatzimpaloglou, Anthoula. “Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας.” 2020. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/47341.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chatzimpaloglou, Anthoula. “Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας.” 2020. Web. 14 Apr 2021.

Vancouver:

Chatzimpaloglou A. Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/47341.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chatzimpaloglou A. Μελέτη της φωτοκαταλυτικής διάσπασης επιλεγμένων αντικαρκινικών ενώσεων και ανάλυση των προϊόντων τους με φασματομετρία μάζας. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2020. Available from: http://hdl.handle.net/10442/hedi/47341

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Wayne State University

28. Yang, Fei. Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea.

Degree: PhD, Nutrition and Food Science, 2020, Wayne State University

Irinotecan is a derived compound from the plant alkaloid camptothecin (CPT). It specifically inhibits eukaryotic DNA enzyme topoisomerase I. Irinotecan was approved by the… (more)

Subjects/Keywords: bacterial β-glucuronidase; delayed diarrhea; irinotecan; Morinda citrifolia; noni fruits; specific inhibitors; Food Science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yang, F. (2020). Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea. (Doctoral Dissertation). Wayne State University. Retrieved from https://digitalcommons.wayne.edu/oa_dissertations/2515

Chicago Manual of Style (16th Edition):

Yang, Fei. “Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea.” 2020. Doctoral Dissertation, Wayne State University. Accessed April 14, 2021. https://digitalcommons.wayne.edu/oa_dissertations/2515.

MLA Handbook (7th Edition):

Yang, Fei. “Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea.” 2020. Web. 14 Apr 2021.

Vancouver:

Yang F. Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea. [Internet] [Doctoral dissertation]. Wayne State University; 2020. [cited 2021 Apr 14]. Available from: https://digitalcommons.wayne.edu/oa_dissertations/2515.

Council of Science Editors:

Yang F. Development Of Specific Natural Bacterial Beta-Glucuronidase Inhibitors For Reducing Irinotecan-Associated Diarrhea. [Doctoral Dissertation]. Wayne State University; 2020. Available from: https://digitalcommons.wayne.edu/oa_dissertations/2515

29. Gianni, Eleni. Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations.

Degree: 2020, University of Patras; Πανεπιστήμιο Πατρών

Halloysite is a clay mineral of kaolinite group with tubular morphology. Due to its special characteristics, it is widely used for the encapsulation of a… (more)

Subjects/Keywords: Άργιλοι και αργιλικά ορυκτά; Αλλουσίτης; Σύστημα μεταφοράς φαρμάκου; Ιρινοτεκάνη; Μοριακή προσομοίωση; Clay minerals; Halloysite; Drug delivery systems; Irinotecan; Molecular simulations

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gianni, E. (2020). Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations. (Thesis). University of Patras; Πανεπιστήμιο Πατρών. Retrieved from http://hdl.handle.net/10442/hedi/47710

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gianni, Eleni. “Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations.” 2020. Thesis, University of Patras; Πανεπιστήμιο Πατρών. Accessed April 14, 2021. http://hdl.handle.net/10442/hedi/47710.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gianni, Eleni. “Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations.” 2020. Web. 14 Apr 2021.

Vancouver:

Gianni E. Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations. [Internet] [Thesis]. University of Patras; Πανεπιστήμιο Πατρών; 2020. [cited 2021 Apr 14]. Available from: http://hdl.handle.net/10442/hedi/47710.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gianni E. Nanocomposites based on halloysite as carriers for anticancer drugs: experimental data and molecular simulations. [Thesis]. University of Patras; Πανεπιστήμιο Πατρών; 2020. Available from: http://hdl.handle.net/10442/hedi/47710

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Paris-Sud – Paris XI

30. Chu, Céline. Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs.

Degree: Docteur es, Pharmacologie experimentale et clinique, 2013, Université Paris-Sud – Paris XI

La P-glycoprotéine (P-gp) est une protéine transmembranaire de la famille des ATP binding cassette transporteurs. Elle est impliquée dans l’efflux du milieu intracellulaire vers le… (more)

Subjects/Keywords: Evérolimus; Lapatinib; Cétuximab; Irinotécan; P-glycoprotéine; Xénogreffe de cancer colorectal; Everolimus; Lapatinib; Cetuximab; Irinotecan; P-glycoprotein; Colorectal carcinoma xenograft

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chu, C. (2013). Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2013PA114806

Chicago Manual of Style (16th Edition):

Chu, Céline. “Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs.” 2013. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed April 14, 2021. http://www.theses.fr/2013PA114806.

MLA Handbook (7th Edition):

Chu, Céline. “Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs.” 2013. Web. 14 Apr 2021.

Vancouver:

Chu C. Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2013. [cited 2021 Apr 14]. Available from: http://www.theses.fr/2013PA114806.

Council of Science Editors:

Chu C. Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1 : Effect of two epidermal growth factor receptor (EGFR) targeting drugs, cetuximab and lapatinib, on P-glycoprotein (ABCB1) and their influence on pharmacokinetics and antitumoral efficiency of ABCB1 substrate drugs. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2013. Available from: http://www.theses.fr/2013PA114806

[1] [2] [3]

.